Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Sales | 1,867,300 | 1,947,100 | 1,827,600 | 1,694,200 | 1,761,300 |
| Cost of Goods | 423,400 | 522,400 | 521,500 | 494,400 | 486,000 |
| Gross Profit | 1,443,900 | 1,424,700 | 1,306,100 | 1,199,800 | 1,275,300 |
| Operating Expenses | 956,500 | 1,067,900 | 903,600 | 925,800 | 866,500 |
| Operating Income | 487,800 | 357,200 | 403,000 | 274,400 | 408,800 |
| Interest Expense | 24,900 | 25,300 | 23,300 | 25,500 | 29,300 |
| Other Income | -18,600 | 73,200 | 22,700 | 79,300 | 19,600 |
| Pre-tax Income | 444,300 | 405,100 | 402,400 | 328,200 | 399,100 |
| Income Tax | 115,500 | 106,100 | 104,600 | 124,100 | 103,800 |
| Net Income Continuous | 329,000 | 278,800 | 297,300 | 219,800 | 276,100 |
| Net Income Discontinuous | 0 | 0 | 200 | 0 | 3,000 |
| Net Income | $329,000 | $278,800 | $297,500 | $219,800 | $279,100 |
| EPS Basic Total Ops | 0.08 | 0.07 | 0.07 | 0.03 | 0.04 |
| EPS Basic Continuous Ops | 0.08 | 0.07 | 0.07 | 0.03 | 0.04 |
| EPS Diluted Total Ops | 0.08 | 0.07 | 0.07 | 0.03 | 0.03 |
| EPS Diluted Continuous Ops | 0.08 | 0.07 | 0.07 | 0.03 | 0.03 |
| EBITDA(a) | $487,800 | $357,200 | $403,000 | $274,400 | $408,800 |